COMMD4

gene
On this page

Also known as FLJ20452

Summary

COMMD4 (COMM domain containing 4, HGNC:26027) is a protein-coding gene on chromosome 15q24.2, encoding COMM domain-containing protein 4 (Q9H0A8). Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex.

Predicted to be involved in signal transduction. Located in cytosol; intracellular membrane-bounded organelle; and plasma membrane.

Source: NCBI Gene 54939 — RefSeq curated summary.

At a glance

  • GWAS associations: 6
  • Clinical variants (ClinVar): 52 total — 1 pathogenic
  • MANE Select transcript: NM_017828

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26027
Approved symbolCOMMD4
NameCOMM domain containing 4
Location15q24.2
Locus typegene with protein product
StatusApproved
AliasesFLJ20452
Ensembl geneENSG00000140365
Ensembl biotypeprotein_coding
OMIM616701
Entrez54939

Gene structure

Transcript identifiers

Ensembl transcripts: 46 — 28 protein_coding, 14 retained_intron, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000267935, ENST00000338995, ENST00000480484, ENST00000561662, ENST00000562310, ENST00000562610, ENST00000562789, ENST00000563220, ENST00000564068, ENST00000564587, ENST00000564815, ENST00000565517, ENST00000565834, ENST00000566230, ENST00000566843, ENST00000567023, ENST00000567195, ENST00000567377, ENST00000567399, ENST00000567720, ENST00000567935, ENST00000568034, ENST00000568301, ENST00000568877, ENST00000569245, ENST00000869634, ENST00000869635, ENST00000869636, ENST00000869637, ENST00000869638, ENST00000869639, ENST00000869640, ENST00000869641, ENST00000928185, ENST00000928186, ENST00000928187, ENST00000928188, ENST00000928189, ENST00000928190, ENST00000928191, ENST00000928192, ENST00000928193, ENST00000928194, ENST00000928195, ENST00000944821, ENST00000944822

RefSeq mRNA: 9 — MANE Select: NM_017828 NM_001284377, NM_001284378, NM_001284379, NM_001321844, NM_001321845, NM_001321846, NM_001321847, NM_001321848, NM_017828

CCDS: CCDS10277, CCDS66834, CCDS66835, CCDS73764, CCDS81909

Canonical transcript exons

ENST00000267935 — 8 exons

ExonStartEnd
ENSE000014248297533606375336092
ENSE000018427777533996575340273
ENSE000034631527533926475339344
ENSE000035337547533835575338420
ENSE000035524417533970275339878
ENSE000035740277533864675338685
ENSE000035854507533898575339104
ENSE000036197727533806275338133

Expression profiles

Bgee: expression breadth ubiquitous, 280 present calls, max score 97.71.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.0299 / max 69.9234, expressed in 1778 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1477989.21291751
1477971.0864763
1477990.7307434

Top tissues by expression

290 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453397.71gold quality
right testisUBERON:000453497.59gold quality
right adrenal glandUBERON:000123397.45gold quality
right adrenal gland cortexUBERON:003582797.41gold quality
left adrenal gland cortexUBERON:003582597.24gold quality
left adrenal glandUBERON:000123497.13gold quality
adrenal cortexUBERON:000123596.89gold quality
granulocyteCL:000009496.66gold quality
mucosa of transverse colonUBERON:000499196.16gold quality
metanephros cortexUBERON:001053396.13gold quality
apex of heartUBERON:000209895.88gold quality
adrenal glandUBERON:000236995.73gold quality
stromal cell of endometriumCL:000225595.51gold quality
testisUBERON:000047395.47gold quality
body of stomachUBERON:000116195.40gold quality
right lobe of thyroid glandUBERON:000111995.11gold quality
adenohypophysisUBERON:000219695.07gold quality
left lobe of thyroid glandUBERON:000112095.01gold quality
transverse colonUBERON:000115794.70gold quality
minor salivary glandUBERON:000183094.62gold quality
C1 segment of cervical spinal cordUBERON:000646994.57gold quality
right lobe of liverUBERON:000111494.54gold quality
muscle layer of sigmoid colonUBERON:003580594.51gold quality
mucosa of stomachUBERON:000119994.43gold quality
endometrium epitheliumUBERON:000481194.42gold quality
right uterine tubeUBERON:000130294.40gold quality
ectocervixUBERON:001224994.38gold quality
lower esophagusUBERON:001347394.36gold quality
lower esophagus muscularis layerUBERON:003583394.36gold quality
left coronary arteryUBERON:000162694.34gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-MTAB-11121yes289.70
E-ANND-3yes8.08

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

9 targeting COMMD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-320299.6667.702737
HSA-MIR-513C-5P99.5068.421730
HSA-MIR-514B-5P99.5068.191766
HSA-MIR-431699.3765.751360
HSA-MIR-3074-5P98.8266.561414
HSA-MIR-227897.3066.191130

Literature-anchored findings (GeneRIF, showing 2)

  • Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer. (PMID:32439936)
  • COMMD4 functions with the histone H2A-H2B dimer for the timely repair of DNA double-strand breaks. (PMID:33875784)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriocommd4ENSDARG00000061946
mus_musculusCommd4ENSMUSG00000032299
rattus_norvegicusCommd4ENSRNOG00000018671
drosophila_melanogasterCG34039FBGN0054039
caenorhabditis_elegansT28F2.2WBGENE00020901

Protein

Protein identifiers

COMM domain-containing protein 4Q9H0A8 (reviewed: Q9H0A8)

All UniProt accessions (7): Q9H0A8, A0A0B4J287, H3BM91, H3BPG2, H3BQF2, H3BRX0, H3BTV9

UniProt curated annotations — full annotation on UniProt →

Function. Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex. May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes. Down-regulates activation of NF-kappa-B.

Subunit / interactions. Component of the commander complex consisting of the CCC subcomplex and the retriever subcomplex. Component of the CCC (COMMD/CCDC22/CCDC93) subcomplex consisting of COMMD1, COMMD2, COMMD3, COMMD4, COMMD5, COMMD6, COMMD7, COMMD8, COMMD9, COMMD10, CCDC22 and CCDC93; within the complex forms a heterodimer with COMMD8. Interacts with RELA, RELB, NFKB1/p105. Interacts with CCDC22, CCDC93, SCNN1B, CUL2, CUL3, CUL4A, CUL5, CUL7.

Subcellular location. Cytoplasm. Nucleus.

Tissue specificity. Ubiquitous.

Similarity. Belongs to the COMM domain-containing protein 4 family.

Isoforms (3)

UniProt IDNamesCanonical?
Q9H0A8-11yes
Q9H0A8-22
Q9H0A8-33

RefSeq proteins (9): NP_001271306, NP_001271307, NP_001271308, NP_001308773, NP_001308774, NP_001308775, NP_001308776, NP_001308777, NP_060298* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR017920COMMDomain
IPR037356COMMD4Family
IPR047155COMMD4/6/7/8Family

Pfam: PF07258, PF21672

UniProt features (16 total): helix 8, strand 3, splice variant 2, chain 1, domain 1, turn 1

Structure

Experimental structures (PDB)

4 structures.

PDBMethodResolution (Å)
9ZMZX-RAY DIFFRACTION2.12
8P0WELECTRON MICROSCOPY2.9
8F2RELECTRON MICROSCOPY3.12
8F2UELECTRON MICROSCOPY3.53

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H0A8-F180.850.08

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-8951664Neddylation

MSigDB gene sets: 141 (showing top): MULLIGHAN_NPM1_SIGNATURE_3_UP, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ENDOCYTIC_RECYCLING, BASAKI_YBX1_TARGETS_UP, GOBP_LOCALIZATION_WITHIN_MEMBRANE, NUYTTEN_EZH2_TARGETS_DN, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, GOCC_MEMBRANE_PROTEIN_COMPLEX, MORF_RAN, MULLIGHAN_MLL_SIGNATURE_1_UP, MORF_CSNK2B, MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP, MORF_PSMC1, MORF_G22P1, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION

GO Biological Process (1): signal transduction (GO:0007165)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (4): nucleus (GO:0005634), cytoplasm (GO:0005737), cytosol (GO:0005829), plasma membrane (GO:0005886)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Post-translational protein modification1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
binding1
intracellular membrane-bounded organelle1
intracellular anatomical structure1
cytoplasm1
membrane1
cell periphery1

Protein interactions and networks

STRING

1779 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
COMMD4COMMD2Q86X83832
COMMD4CCDC22O60826775
COMMD4COMMD3Q9UBI1775
COMMD4COMMD9Q9P000760
COMMD4COMMD1Q8N668671
COMMD4VPS26CO14972634
COMMD4COMMD5Q9GZQ3627
COMMD4COMMD8Q9NX08621
COMMD4COMMD6Q7Z4G1614
COMMD4COMMD10Q9Y6G5571
COMMD4DPM3Q9P2X0514
COMMD4A0A2R8Y455A0A2R8Y455507
COMMD4COMMD7Q86VX2506
COMMD4ACYP1P07311476
COMMD4R4GMX3R4GMX3471

IntAct

109 interactions, top by confidence:

ABTypeScore
COMMD1CCDC22psi-mi:“MI:0914”(association)0.970
CCDC22CCDC93psi-mi:“MI:0915”(physical association)0.960
CCDC22CCDC93psi-mi:“MI:0914”(association)0.960
COMMD1COMMD6psi-mi:“MI:0914”(association)0.950
COMMD1COMMD6psi-mi:“MI:0915”(physical association)0.950
CCDC22COMMD6psi-mi:“MI:0914”(association)0.930
COMMD2CCDC22psi-mi:“MI:0914”(association)0.930
CCDC22COMMD4psi-mi:“MI:0915”(physical association)0.920
COMMD1COMMD4psi-mi:“MI:0915”(physical association)0.920
COMMD4COMMD8psi-mi:“MI:0915”(physical association)0.880
COMMD4COMMD8psi-mi:“MI:0914”(association)0.880
ODAD1HGSpsi-mi:“MI:0914”(association)0.850
COMMD2COMMD4psi-mi:“MI:0915”(physical association)0.820
COMMD4CCDC93psi-mi:“MI:0915”(physical association)0.800
CCDC22VPS26Cpsi-mi:“MI:0914”(association)0.790
VPS29VPS26Cpsi-mi:“MI:0914”(association)0.760
COMMD1VPS26Cpsi-mi:“MI:0914”(association)0.730
COMMD4VPS26Cpsi-mi:“MI:0914”(association)0.730
E2F6WDR5psi-mi:“MI:0914”(association)0.730

BioGRID (195): COMMD4 (Affinity Capture-MS), COMMD4 (Affinity Capture-MS), COMMD4 (Affinity Capture-MS), COMMD4 (Affinity Capture-MS), COMMD4 (Affinity Capture-MS), COMMD2 (Affinity Capture-MS), C16orf62 (Affinity Capture-MS), CCDC93 (Affinity Capture-MS), COMMD10 (Affinity Capture-MS), TP53RK (Affinity Capture-MS), EXOSC4 (Affinity Capture-MS), COMMD7 (Affinity Capture-MS), FAM45A (Affinity Capture-MS), EXOSC2 (Affinity Capture-MS), COMMD6 (Affinity Capture-MS)

ESM2 similar proteins: A4IFQ0, A4QNE0, O09172, O75031, P41214, P48507, P48508, P48553, P50747, P54198, Q08BT5, Q0P5I8, Q13769, Q2T9Y6, Q2TBN5, Q3B7L5, Q3T0J1, Q3TLI0, Q5E9V6, Q5R812, Q5RA63, Q5RAQ5, Q61666, Q66H91, Q68FF6, Q68FX7, Q6DFV5, Q6NRL4, Q6P6Y1, Q6ZPY2, Q76JQ2, Q7L5D6, Q8BKT7, Q8JZY2, Q8K2Q0, Q8R1T1, Q8WUX9, Q91W86, Q91W96, Q920N2

Diamond homologs: Q550I8, Q5E9V6, Q9CQ02, Q9H0A8

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 64 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Neddylation1113.0×1e-07

GO biological processes:

GO termPartnersFoldFDR
endocytic recycling628.2×3e-05
cilium assembly810.3×2e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

52 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance34
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
58080GRCh38/hg38 15q24.2(chr15:75336215-75658670)x3Pathogenic

SpliceAI

1446 predictions. Top by Δscore:

VariantEffectΔscore
15:75338061:GA:Gacceptor_gain1.0000
15:75338133:GGT:Gdonor_gain1.0000
15:75338135:T:Gdonor_gain1.0000
15:75338135:T:TGdonor_gain1.0000
15:75338139:G:GGdonor_gain1.0000
15:75338353:A:AGacceptor_gain1.0000
15:75338354:G:GGacceptor_gain1.0000
15:75338644:A:AGacceptor_gain1.0000
15:75338645:G:GGacceptor_gain1.0000
15:75338645:GT:Gacceptor_gain1.0000
15:75338684:TGG:Tdonor_loss1.0000
15:75338685:GGT:Gdonor_loss1.0000
15:75338686:GT:Gdonor_loss1.0000
15:75338973:C:CAacceptor_gain1.0000
15:75339341:CGCA:Cdonor_gain1.0000
15:75339342:GCA:Gdonor_gain1.0000
15:75339342:GCAG:Gdonor_gain1.0000
15:75339343:CA:Cdonor_gain1.0000
15:75339343:CAG:Cdonor_loss1.0000
15:75339344:AGT:Adonor_loss1.0000
15:75339345:G:GGdonor_gain1.0000
15:75339346:TAA:Tdonor_loss1.0000
15:75339700:A:AGacceptor_gain1.0000
15:75339701:G:GGacceptor_gain1.0000
15:75339701:GTGA:Gacceptor_gain1.0000
15:75336093:G:GGdonor_gain0.9900
15:75336094:T:Gdonor_loss0.9900
15:75336098:GCAC:Gdonor_gain0.9900
15:75338057:TGCA:Tacceptor_loss0.9900
15:75338058:GCA:Gacceptor_loss0.9900

AlphaMissense

1283 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
15:75338065:T:CF3L0.999
15:75338067:C:AF3L0.999
15:75338067:C:GF3L0.999
15:75338098:T:AW14R0.999
15:75338098:T:CW14R0.999
15:75338100:G:CW14C0.999
15:75338100:G:TW14C0.999
15:75339081:T:CL93P0.997
15:75338066:T:CF3S0.996
15:75338066:T:GF3C0.996
15:75339096:T:CL98P0.996
15:75338071:T:CF5L0.995
15:75338073:C:AF5L0.995
15:75338073:C:GF5L0.995
15:75338091:T:GC11W0.995
15:75339093:G:AG97E0.995
15:75338089:T:CC11R0.994
15:75339968:T:CL188P0.994
15:75338065:T:GF3V0.993
15:75338078:G:TG7V0.993
15:75338090:G:AC11Y0.993
15:75338105:T:CL16P0.993
15:75339090:T:CL96P0.993
15:75338099:G:TW14L0.992
15:75339039:C:AA79E0.992
15:75339078:A:TE92V0.992
15:75339092:G:AG97R0.992
15:75339092:G:CG97R0.992
15:75338065:T:AF3I0.991
15:75338099:G:CW14S0.991

dbSNP variants (sampled 300 via entrez): RS1000233675 (15:75334743 A>C), RS1000302644 (15:75339554 C>A,G,T), RS1000694685 (15:75338291 G>C), RS1000771377 (15:75343652 T>G), RS1000890935 (15:75338466 A>C,G), RS1000967784 (15:75342917 C>G), RS1001854713 (15:75342887 T>C,G), RS1002030519 (15:75341401 G>A,T), RS1003627901 (15:75335163 A>G), RS1004184441 (15:75339786 A>C), RS1004590468 (15:75341042 G>C), RS1004644507 (15:75340831 G>A), RS1004820075 (15:75336346 G>C), RS1005089694 (15:75336518 C>A,T), RS1005334432 (15:75342631 C>T)

Disease associations

OMIM: gene MIM:616701 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

6 associations (top):

StudyTraitp-value
GCST007725_8Serum uric acid levels1.000000e-08
GCST008790_51Urinary albumin-to-creatinine ratio4.000000e-16
GCST008791_10Microalbuminuria2.000000e-07
GCST008971_14Urate levels2.000000e-07
GCST008972_197Urate levels3.000000e-12
GCST008972_43Urate levels3.000000e-07

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004761uric acid measurement
EFO:0007778urinary albumin to creatinine ratio
EFO:0004531urate measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

40 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression, increases abundance2
cobaltous chloridedecreases expression2
TAK-243increases sumoylation1
2,4,6-tribromophenoldecreases expression1
methylmercuric chloridedecreases expression1
lasiocarpineincreases expression1
bisphenol Aaffects expression1
decabromobiphenyl etherdecreases expression1
beta-lapachoneincreases expression1
arseniteaffects binding, increases reaction1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
cypermethrinincreases expression1
tetrabromobisphenol Adecreases expression1
zinc chromatedecreases expression, increases abundance1
cupric chloridedecreases expression1
di-n-butylphosphoric acidaffects expression1
chromium hexavalent iondecreases expression, increases abundance1
K 7174decreases expression1
erucylphospho-N,N,N-trimethylpropylammoniumdecreases expression1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1
Grape Seed Proanthocyanidinsaffects cotreatment, decreases expression1
pentabrominated diphenyl ether 100decreases expression1
hexabrominated diphenyl ether 153decreases expression1
jinfukangincreases expression1
(+)-JQ1 compounddecreases expression1
Sunitinibdecreases expression1
Vorinostatincreases expression1
Arsenicincreases abundance, increases expression1
Catechinaffects cotreatment, decreases expression1
Cisplatinincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.